| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | INJECTION / PARENTERAL | | 18 mg | Exact identifier — unii candidate 79 equally ranked IID candidates |
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | AEROSOL, FOAM / VAGINAL | 0.1 %w/w | | Exact identifier — unii candidate 79 equally ranked IID candidates |
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | AEROSOL, FOAM / TOPICAL | 8 %w/w | | Exact identifier — unii candidate 26 equally ranked IID candidates |
| PROPYLENE GLYCOL MONOPALMITOSTEARATE | PROPYLENE GLYCOL MONOPALMITOSTEARATE | F76354LMGR | CREAM / TOPICAL | 9.3 %w/w | | Exact identifier — unii candidate 6 equally ranked IID candidates |
| SORBITOL | SORBITOL | 506T60A25R | CONCENTRATE / ORAL | 600 mg/1ml | | Exact identifier — unii candidate 44 equally ranked IID candidates |
| SORBITOL | SORBITOL | 506T60A25R | TABLET / ORAL | 337.28 mg | | Exact identifier — unii candidate 44 equally ranked IID candidates |
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | EMULSION / ORAL | NA | | Exact identifier — unii candidate 26 equally ranked IID candidates |
| POLYSORBATE 40 | POLYSORBATE 40 | STI11B5A2X | ELIXIR / ORAL | 0.05 mg/5ml | | Exact identifier — unii candidate 7 equally ranked IID candidates |
| ISOPROPYL MYRISTATE | ISOPROPYL MYRISTATE | 0RE8K4LNJS | GEL / TOPICAL | | 29 mg | Exact identifier — unii candidate 18 equally ranked IID candidates |
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | TABLET / SUBLINGUAL | 9 mg | | Exact identifier — unii candidate 26 equally ranked IID candidates |
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | CREAM / VAGINAL | | 1225 mg | Exact identifier — unii candidate 81 equally ranked IID candidates |
| SORBITOL | SORBITOL | 506T60A25R | INJECTION, SOLUTION / INTRAVENOUS | | 4050 mg | Exact identifier — unii candidate 44 equally ranked IID candidates |
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | AEROSOL, FOAM / VAGINAL | 4 %w/w | | Exact identifier — unii candidate 26 equally ranked IID candidates |
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | SOLUTION / OPHTHALMIC | 0.05 %w/w | | Exact identifier — unii candidate 79 equally ranked IID candidates |
| SORBITOL | SORBITOL | 506T60A25R | SYSTEM / TOPICAL | | 6300 mg | Exact identifier — unii candidate 44 equally ranked IID candidates |
| SORBITOL | SORBITOL | 506T60A25R | SOLUTION / ORAL | | 29268 mg | Exact identifier — unii candidate 44 equally ranked IID candidates |
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | AEROSOL, METERED / RECTAL | NA | | Exact identifier — unii candidate 81 equally ranked IID candidates |
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | GEL / RECTAL | | 3315 mg | Exact identifier — unii candidate 81 equally ranked IID candidates |
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | SHAMPOO, SUSPENSION / TOPICAL | 0.15 %w/w | | Exact identifier — unii candidate 79 equally ranked IID candidates |
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | TABLET, COATED / ORAL | | 16 mg | Exact identifier — unii candidate 81 equally ranked IID candidates |
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | LIQUID / RESPIRATORY (INHALATION) | 10 %w/w | | Exact identifier — unii candidate 81 equally ranked IID candidates |
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | INJECTION, SOLUTION / SUBCUTANEOUS | 1.4 %w/v | | Exact identifier — unii candidate 81 equally ranked IID candidates |
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | SUSPENSION, EXTENDED RELEASE / ORAL | | 1000 mg | Exact identifier — unii candidate 81 equally ranked IID candidates |
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | INJECTION, SOLUTION / INTRAVENOUS | | 4000 mg | Exact identifier — unii candidate 81 equally ranked IID candidates |
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | SPRAY, METERED / NASAL | | 240 mg | Exact identifier — unii candidate 81 equally ranked IID candidates |
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | TABLET, EXTENDED RELEASE / ORAL | 0.17 mg | | Exact identifier — unii candidate 79 equally ranked IID candidates |
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | SUSPENSION/ DROPS / OPHTHALMIC | 0.75 %w/v | | Exact identifier — unii candidate 81 equally ranked IID candidates |
| SORBITOL | SORBITOL | 506T60A25R | INJECTION / INTRAMUSCULAR | NA | | Exact identifier — unii candidate 44 equally ranked IID candidates |
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | GRANULE, FOR SUSPENSION / ORAL | | 80 mg | Exact identifier — unii candidate 79 equally ranked IID candidates |
| ISOPROPYL MYRISTATE | ISOPROPYL MYRISTATE | 0RE8K4LNJS | LOTION / TOPICAL | | 50 mg | Exact identifier — unii candidate 18 equally ranked IID candidates |
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | ENEMA / RECTAL | 0.18 %w/v | | Exact identifier — unii candidate 79 equally ranked IID candidates |
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | GEL / TOPICAL | | 24 mg | Exact identifier — unii candidate 79 equally ranked IID candidates |
| SORBITOL | SORBITOL | 506T60A25R | POWDER, FOR SUSPENSION / ORAL | | 12000 mg | Exact identifier — unii candidate 44 equally ranked IID candidates |
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | INJECTION / INTRAMUSCULAR | | 7459 mg | Exact identifier — unii candidate 81 equally ranked IID candidates |
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | FILM, EXTENDED RELEASE / TRANSDERMAL | 58.13 mg | | Exact identifier — unii candidate 81 equally ranked IID candidates |
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | AEROSOL, FOAM / TOPICAL | 0.16 %w/w | | Exact identifier — unii candidate 79 equally ranked IID candidates |
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | PELLET / SUBCUTANEOUS | 0.97 mg | | Exact identifier — unii candidate 26 equally ranked IID candidates |
| BUTYLPARABEN | BUTYLPARABEN | 3QPI1U3FV8 | LOTION / TOPICAL | | 4 mg | Exact identifier — unii candidate 15 equally ranked IID candidates |
| ISOPROPYL MYRISTATE | ISOPROPYL MYRISTATE | 0RE8K4LNJS | SUSPENSION / AURICULAR (OTIC) | 0.02 %w/w | | Exact identifier — unii candidate 18 equally ranked IID candidates |
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | FILM, SOLUBLE / BUCCAL | | 5 mg | Exact identifier — unii candidate 81 equally ranked IID candidates |
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | TABLET, FILM COATED / ORAL | | 176 mg | Exact identifier — unii candidate 26 equally ranked IID candidates |
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | ELIXIR / ORAL | | 9306 mg | Exact identifier — unii candidate 81 equally ranked IID candidates |
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | INJECTION, POWDER, FOR SOLUTION / INTRAVENOUS | 15 mg | | Exact identifier — unii candidate 79 equally ranked IID candidates |
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | SUSPENSION / ORAL | | 27120 mg | Exact identifier — unii candidate 81 equally ranked IID candidates |
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | SUSPENSION / AURICULAR (OTIC) | NA | | Exact identifier — unii candidate 79 equally ranked IID candidates |
| SORBITOL | SORBITOL | 506T60A25R | TABLET, COATED / ORAL | 12.96 mg | | Exact identifier — unii candidate 44 equally ranked IID candidates |
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | GEL / OPHTHALMIC | 0.44 %w/w | | Exact identifier — unii candidate 81 equally ranked IID candidates |
| SORBITOL | SORBITOL | 506T60A25R | TABLET, EXTENDED RELEASE / ORAL | | 428 mg | Exact identifier — unii candidate 44 equally ranked IID candidates |
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | INJECTION / INTRA-ARTICULAR | 0.24 %w/v | | Exact identifier — unii candidate 79 equally ranked IID candidates |
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | POWDER, FOR SOLUTION / ORAL | | 126 mg | Exact identifier — unii candidate 79 equally ranked IID candidates |
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | TABLET / BUCCAL | 6 mg | | Exact identifier — unii candidate 26 equally ranked IID candidates |
| BUTYLPARABEN | BUTYLPARABEN | 3QPI1U3FV8 | LIQUID / TOPICAL | 0.02 %w/w | | Exact identifier — unii candidate 15 equally ranked IID candidates |
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | TABLET, CHEWABLE / ORAL | 1.28 mg | | Exact identifier — unii candidate 79 equally ranked IID candidates |
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | SOLUTION/ DROPS / OPHTHALMIC | 0.75 %w/v | | Exact identifier — unii candidate 81 equally ranked IID candidates |
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | OINTMENT, AUGMENTED / TOPICAL | | 714 mg | Exact identifier — unii candidate 81 equally ranked IID candidates |
| BUTYLPARABEN | BUTYLPARABEN | 3QPI1U3FV8 | SUSPENSION / ORAL | | 12 mg | Exact identifier — unii candidate 15 equally ranked IID candidates |
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | INJECTION / INTRAMUSCULAR | | 95 mg | Exact identifier — unii candidate 79 equally ranked IID candidates |
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | TABLET, ORALLY DISINTEGRATING / ORAL | | 10 mg | Exact identifier — unii candidate 26 equally ranked IID candidates |
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | | 19 mg | Exact identifier — unii candidate 81 equally ranked IID candidates |
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | SOLUTION / INTRAMUSCULAR | 0.13 %w/v | | Exact identifier — unii candidate 79 equally ranked IID candidates |